We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Workflow level release of microplastics, nanoplastics, and perfluoroalkyl and polyfluoroalkyl substances during simulated neurovascular interventions
AI summary Read the abstract
A lab study found that catheters and devices used to treat brain blood clots and aneurysms can shed tiny plastic particles and "forever chemicals" (PFAS) into fluids during the procedure. This suggests patients may be exposed to these contaminants during treatment, highlighting a need for further safety testing of medical device materials.
BACKGROUND: Catheter based neurovascular interventions rely on polymer based, coated, and fluorinated devices. Mechanical manipulation may release particulate and molecular contaminants, but integrated workflow level quantification of microplastic (MP), nanoplastic (NP), and perfluoroalkyl and polyfluoroalkyl substance (PFAS) release during neurovascular procedures remains limited. This study quantified MP, NP, and PFAS release in an in vitro simulation of neurointerventional workflows. METHODS: 20 neurovascular procedures were simulated under standardized in vitro conditions, including 10 mechanical thrombectomy and 10 aneurysm treatment workflows. Procedures were performed in 5 L glass containers using warmed saline, contrast medium, and clinically applied neurovascular devices. Procedural fluid was collected after each simulation and aliquoted for MP, NP, and PFAS analysis using micro-Fourier transform infrared spectroscopy, pyrolysis-gas chromatography-mass spectrometry, and ultra high performance liquid chromatography-tandem mass spectrometry, respectively. RESULTS: Contaminants were detected across all simulated procedures. Median MP particle count was 15 particles per analyzed sample volume (IQR 9.0-27.3; range 0-58), median NP concentration was 18.19 µg/L (IQR 5.85-33.35; range 2.19-1671.10), and median sum PFAS concentration was 127 µg/L (IQR 93.5-272.0; range 47-458). MP and NP levels did not differ between thrombectomy and aneurysm simulations. Sum PFAS concentrations were higher during thrombectomy than during aneurysm treatment simulations (median 209.5 vs 98.0 µg/L; P=0.010), particularly in stent retriever compared with direct aspiration simulations (median 287.0 vs 120.0 µg/L; P=0.030). NP and sum PFAS concentrations were strongly correlated (ρ=0.689; P=0.001). CONCLUSIONS: Simulated neurovascular interventions generated measurable release of MP, NP, and PFAS into procedural fluid. Workflow level assessment may support future source specific testing, clinical validation, and material safety evaluation.
More Papers Like This
Microplastics release from coronary catheters: Insights from catheter analysis
AI summary Read the abstract
This study examined whether cardiac catheters used in heart procedures release microplastic particles, and found that all 21 catheter samples tested shed microplastics of varying sizes and types. The findings raise important questions about patient safety, since these tiny plastic fragments could enter the bloodstream during routine cardiovascular procedures.
Percutaneous coronary intervention leads to microplastics entering the blood: Interventional devices are a major source
AI summary Read the abstract
Researchers measured microplastic levels in the blood of 23 patients before and after heart stent procedures (percutaneous coronary intervention) and found that microplastic concentrations jumped nearly 19-fold after the procedure. The types of plastics found in the blood matched those detected on the medical devices used during the procedure, confirming that the devices themselves were the source. This study reveals that common medical procedures using plastic equipment may be an overlooked route for microplastics to enter the human bloodstream.
The role of per- and polyfluoroalkyl substances in medical devices and delivery systems: Why the electrophysiologist should care
AI summary Read the abstract
This review explains that PFAS chemicals span two distinct classes with very different risk profiles: small water-soluble compounds like PFOA and PFOS are environmental hazards, while fluoropolymers—a separate PFAS class—are essential components of medical devices and cardiac electrophysiology tools due to their unique physical properties.
Detection of micro- and nanoplastics in cerebrospinal fluid and blood: Implications for brain diseases
AI summary Read the abstract
Researchers measured micro- and nanoplastic concentrations in paired cerebrospinal fluid and blood samples from patients with neurological conditions. They detected five types of plastic polymers in both fluids, with blood containing significantly higher concentrations than cerebrospinal fluid, and found correlations between plastic levels in the two fluids among patients with neuroimmune and neuroinfectious conditions. The study also identified disrupted metabolic pathways associated with higher plastic concentrations, suggesting a potential link between plastic particle exposure and changes in brain chemistry that warrants further investigation.
Microplastic in perfusion: the hidden risk and how to address it
AI summary Read the abstract
This commentary addresses the emerging concern that cardiopulmonary bypass circuits and other extracorporeal circulation systems release significant levels of micro- and nanoplastics into patients during medical procedures. The authors note that the same properties making plastics ideal for medical tubing also make their degradation products potentially harmful. The study calls for further research into the clinical implications of plastic particle exposure during these increasingly common medical interventions.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.